Efficacy and Safety of Certolizumab-pegol and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid Arthritis.

Trial Profile

Efficacy and Safety of Certolizumab-pegol and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid Arthritis.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Feb 2012

At a glance

  • Drugs Certolizumab pegol; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Feb 2012 Primary endpoint 'American-College-of-Rheumatology-20%-response-criteria' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top